Fate Therapeutics saw the highest growth of 1.79% in patent filings and 2.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.24% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Fate Therapeutics’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Fate Therapeutics has been focused on protecting inventions in Australia(AU) with four publications in Q2 2024

The Australia(AU) Patent Office dominates the patent filings and grants with nearly 19% filings and 20% grants. The World Intellectual Property Organization(WIPO), Australia(AU), United States(US), and China(CN) patent Office are among the top ten patent offices where Fate Therapeutics is filings its patents. Among the top granted patent authorities, Fate Therapeutics has 20% of its grants in Australia(AU) and 20% in China(CN).

Roche could be the strongest competitor for Fate Therapeutics

Patents related to cell & gene therapy and genomics lead Fate Therapeutics's portfolio

Fate Therapeutics has the highest number of patents in cell & gene therapy followed by, genomics and rare diseases. For cell & gene therapy, nearly 45% of patents were filed and 100% of patents were granted in Q2 2024.

Viral infections related patents lead Fate Therapeutics portfolio followed by solid tumor, and cell therapy

Fate Therapeutics has highest number of patents in viral infections followed by solid tumor, cell therapy, advanced malignancy, and autoimmune disorders. For viral infections, nearly 15% of patents were filed and 33% of patents were granted in Q2 2024.

For comprehensive analysis of Fate Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.